DNA Expert Witnesses in Connecticut

This highly-qualified expert has 14 years of experience in the field of biopharmaceutical development, having earned her BS in biology from the University of North Carolina and her PhD in genetics from the University of California at San Francisco. Her work focuses on drug development with a particular focus on gene and cell therapies, including those with the following elements: AAV, Adenovirus, CRISPR, Zfn, Endonuclease, CAR-T, mRNA, LNP, Lentivirus, HSPC. She has worked in positions such as principal consultant for Halloran Consulting Group, the founder and CEO of Tremont Therapeutics, the senior director of Shire PLC, and the executive director of CRISPR Therapeutics. She is also involved in research in her field as an author of several scientific articles. This expert currently works as the principal at a drug development consulting company in Massachusetts.

This highly qualified, fellowship trained expert has over twenty years of experience in anesthesiology. She is a member of numerous anesthesiology societies, and has held various leadership positions in many of them. She has been presented with multiple awards for her research on obstetric anesthesia, and has over seventy peer reviewed articles and published abstracts on various anesthesiology topics. In her current position as a professor, this highly qualified expert has focused her educational vision around the need to develop a new division of Obstetric Anesthesia at a Washington State medical center. With the goal to build a strong clinical anesthesia program for a particularly high-risk obstetric service providing care to the sickest population in the Pacific Northwest of the USA, she recruited academic anesthesiologists, each with specific skills and expertise, to train obstetric anesthesiologists for a career in academic medicine. She was able to achieve this goal by demonstrating innovative leadership and mentorship, and being a role model as a clinical educator.

This qualified expert earned his BS from the Massachusetts Institute of Technology and his MD from Stanford University School of Medicine. He completed his internship and residency in internal medicine at Mt. Sinai Hospital and his fellowships in rheumatology and clinical immunology at Yale University School of Medicine. In addition to being board certified in internal medicine and rheumatology, this expert has extensive experience in clinical work, academia, and the pharmacy industry. Early in his career, he served as an Internist and Chief of Internal Medicine at Westchester Community Health Plan and Chief of Rheumatology at VAMC-Syracuse. He was a Professor at UMDNJ-Robert Wood Johnson Medical School in the Department of Pediatrics, Medicine, and Molecular Genetics and Microbiology. This expert was also the Medical Director of Immunology at Bristol-Myers Squibb's Pharmaceutical Research Institute, Vice President of NovoNordisk's Medical-Science Inflammation Department, and Vice President of Immunology and Rheumatology at Parexel International. Currently, he is a Clinical Professor at a medical school in New Jersey and is President of a firm that provides consultation services in immunology and rheumatology focusing on molecules in development.